Oncopharmpod
Vepdegestrant
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:11:35
- More information
Informações:
Synopsis
The latest FDA drug approval is vepdegestrant, a heterobifunctional protein degrader, for ESR1 mutated breast cancer. We discuss what that actually means and some possible implications for clinical practice. Check out the Oncology Insights Newsletter: www.kelleycpharmd.com/newsletter-oncopharm
